Ajooni Biotech Limited (NSE:AJOONI)
India · Delayed Price · Currency is INR 3.800
-0.030 (-0.78%)
Jun 19, 2026, 2:39 PM IST
Ajooni Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,824 | 1,147 | 801.15 | 744.88 | 740.38 |
Other Revenue | 24.18 | 11.79 | 1.39 | - | - |
| 1,848 | 1,159 | 802.54 | 744.88 | 740.38 | |
Revenue Growth (YoY) | 59.48% | 44.38% | 7.74% | 0.61% | 45.06% |
Cost of Revenue | 1,479 | 970.28 | 703.5 | 657.43 | 640.13 |
Gross Profit | 368.68 | 188.44 | 99.04 | 87.45 | 100.24 |
Selling, General & Admin | 45.73 | 123.95 | 64.3 | 50.88 | 56.03 |
Other Operating Expenses | 236.21 | 14.04 | 7.06 | 6.8 | 11.57 |
Operating Expenses | 304.01 | 148.92 | 80.1 | 67.73 | 78.7 |
Operating Income | 64.68 | 39.52 | 18.94 | 19.72 | 21.54 |
Interest Expense | -7.29 | - | - | - | - |
Interest & Investment Income | - | 8.88 | 5.06 | 2.05 | 0.01 |
Other Non Operating Income (Expenses) | - | -3.34 | -5.29 | -4.77 | -5.4 |
EBT Excluding Unusual Items | 57.38 | 45.05 | 18.7 | 16.99 | 16.15 |
Other Unusual Items | - | -1.76 | -1.95 | -1.23 | -1.54 |
Pretax Income | 57.38 | 43.29 | 29.96 | 15.77 | 14.61 |
Income Tax Expense | 14.16 | 9.57 | 8.35 | 4.52 | 4.12 |
Net Income | 43.22 | 33.72 | 21.61 | 11.25 | 10.49 |
Net Income to Common | 43.22 | 33.72 | 21.61 | 11.25 | 10.49 |
Net Income Growth | 28.17% | 56.02% | 92.16% | 7.24% | 181.14% |
Shares Outstanding (Basic) | 173 | 172 | 88 | 60 | 51 |
Shares Outstanding (Diluted) | 173 | 172 | 88 | 60 | 51 |
Shares Change (YoY) | 0.37% | 96.59% | 46.51% | 18.35% | 1.00% |
EPS (Basic) | 0.25 | 0.20 | 0.25 | 0.19 | 0.21 |
EPS (Diluted) | 0.25 | 0.20 | 0.25 | 0.19 | 0.21 |
EPS Growth | 27.70% | -20.64% | 31.16% | -9.39% | 180.50% |
Free Cash Flow | -237.62 | -197.69 | 173.09 | -69.39 | 15.6 |
Free Cash Flow Per Share | -1.38 | -1.15 | 1.98 | -1.16 | 0.31 |
Gross Margin | 19.95% | 16.26% | 12.34% | 11.74% | 13.54% |
Operating Margin | 3.50% | 3.41% | 2.36% | 2.65% | 2.91% |
Profit Margin | 2.34% | 2.91% | 2.69% | 1.51% | 1.42% |
Free Cash Flow Margin | -12.86% | -17.06% | 21.57% | -9.32% | 2.11% |
EBITDA | 86.74 | 50.45 | 27.68 | 29.77 | 31.24 |
EBITDA Margin | 4.69% | 4.35% | 3.45% | 4.00% | 4.22% |
D&A For EBITDA | 22.06 | 10.94 | 8.74 | 10.05 | 9.7 |
EBIT | 64.68 | 39.52 | 18.94 | 19.72 | 21.54 |
EBIT Margin | 3.50% | 3.41% | 2.36% | 2.65% | 2.91% |
Effective Tax Rate | 24.68% | 22.11% | 27.87% | 28.68% | 28.22% |
Revenue as Reported | 1,848 | 1,168 | 823.08 | 747.82 | 740.76 |
Advertising Expenses | - | 0.76 | 0.36 | 0.19 | 0.35 |